Drug Shortage Report for APO-NAPROXEN

Last updated on 2024-02-09 History
Report ID 219171
Drug Identification Number 00592277
Brand name APO-NAPROXEN
Common or Proper name NAPROXEN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NAPROXEN
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-02-06
Estimated end date 2024-05-03
Actual end date
Shortage status Actual shortage
Updated date 2024-02-09
Company comments 500 BTL available
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2024-02-09 French Compare
v1 2024-02-09 English Compare

Showing 1 to 2 of 2